Overview Ogivri is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat breast cancer in cases where tumors overexpress the HER2 protein. Ogivri is also known by its drug name,… read more
Your Cookies
In order to operate the site and better serve you, we collect your data. We also use this data and share with our vendors for the purposes of marketing, research, and monitoring.